Who Decides If a Clinical Trial Is Safe?

When you hear about a clinical trial, a fair question to ask is: who is making sure this is actually safe? The answer is not just one person or one group. There are several layers of oversight working together to protect you.

The FDA

In the United States, the Food and Drug Administration sets the rules for how clinical trials must be run. Before a trial can even begin, researchers have to submit detailed plans showing what they are testing, how, and why. The FDA reviews this and has the authority to stop a trial at any time if safety concerns come up.

Institutional Review Boards (IRBs)

Every clinical trial must be approved by an Institutional Review Board, or IRB. This is an independent group of doctors, researchers, and community members. Their job is to review the trial plan and make sure it is ethical and that participants are protected. They continue to review the trial as it moves forward, not just at the start.

The Research Team

The doctors and researchers running the trial are also watching closely. They track how participants respond throughout the study and are required to report any unexpected problems right away.

You

Your safety also depends on you being informed. Before joining any trial, you go through a process called informed consent. This means the research team explains the risks, the benefits, and your rights in plain language before you agree to anything.

No system is perfect, but clinical trials are among the most closely watched medical processes that exist.

Have questions about a specific trial? Our team is happy to help you make sense of it.

Written By: Carolyn Vandenbroek, MSDM

Reviewed By: Srilata Gundala, MD

Disclaimer: This blog provides general educational information and is not a substitute for medical or psychological advice. Always speak with your healthcare provider and mental health professionals for guidance specific to your situation.